EHC Encompass Health Corp

Price (delayed)

$48.18

Market cap

$4.81B

P/E Ratio

12.17

Dividend/share

$1.12

EPS

$3.96

Enterprise value

$8.16B

Encompass Health Corporation , based in Birmingham, Alabama, is one of the United States' largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states ...

Highlights
The P/E is 41% below the 5-year quarterly average of 20.3 and 34% below the last 4 quarters average of 18.1
The company's equity rose by 19% YoY and by 3.3% QoQ
Encompass Health's EPS has increased by 29% YoY but it has decreased by 4.6% from the previous quarter
Encompass Health's net income has increased by 26% YoY but it has decreased by 4.4% from the previous quarter

Key stats

What are the main financial stats of EHC
Market
Shares outstanding
99.8M
Market cap
$4.81B
Enterprise value
$8.16B
Valuations
Price to earnings (P/E)
12.17
Price to book (P/B)
2.43
Price to sales (P/S)
0.91
EV/EBIT
10.31
EV/EBITDA
7.76
EV/Sales
1.56
Earnings
Revenue
$5.22B
EBIT
$792.2M
EBITDA
$1.05B
Free cash flow
$215.1M
Per share
EPS
$3.96
Free cash flow per share
$2.17
Book value per share
$19.85
Revenue per share
$52.67
TBVPS
$41.1
Balance sheet
Total assets
$6.94B
Total liabilities
$4.5B
Debt
$3.51B
Equity
$1.97B
Working capital
$195.2M
Liquidity
Debt to equity
1.78
Current ratio
1.26
Quick ratio
1.11
Net debt/EBITDA
3.19
Margins
EBITDA margin
20.1%
Gross margin
23.9%
Net margin
9.5%
Operating margin
15%
Efficiency
Return on assets
7.3%
Return on equity
26.4%
Return on invested capital
12.2%
Return on capital employed
12.8%
Return on sales
15.2%
Dividend
Dividend yield
2.32%
DPS
$1.12
Payout ratio
28.3%

EHC stock price

How has the Encompass Health stock price performed over time
Intraday
1.22%
1 week
-14.04%
1 month
-21.49%
1 year
-40.77%
YTD
-26.17%
QTD
-14.04%

Financial performance

How have Encompass Health's revenue and profit performed over time
Revenue
$5.22B
Gross profit
$1.25B
Operating income
$782.7M
Net income
$494.5M
Gross margin
23.9%
Net margin
9.5%
Encompass Health's net income has increased by 26% YoY but it has decreased by 4.4% from the previous quarter
EHC's gross profit is up by 16% YoY
Encompass Health's operating income has increased by 16% YoY but it has decreased by 3% from the previous quarter
The net margin has grown by 13% YoY but it has contracted by 6% from the previous quarter

Growth

What is Encompass Health's growth rate over time

Valuation

What is Encompass Health stock price valuation
P/E
12.17
P/B
2.43
P/S
0.91
EV/EBIT
10.31
EV/EBITDA
7.76
EV/Sales
1.56
The P/E is 41% below the 5-year quarterly average of 20.3 and 34% below the last 4 quarters average of 18.1
Encompass Health's EPS has increased by 29% YoY but it has decreased by 4.6% from the previous quarter
EHC's price to book (P/B) is 47% lower than its 5-year quarterly average of 4.5 and 38% lower than its last 4 quarters average of 3.9
The company's equity rose by 19% YoY and by 3.3% QoQ
EHC's P/S is 36% below its 5-year quarterly average of 1.4 and 36% below its last 4 quarters average of 1.4
Encompass Health's revenue has increased by 11% YoY and by 2% QoQ

Efficiency

How efficient is Encompass Health business performance
Encompass Health's return on assets has increased by 22% YoY but it has decreased by 5% QoQ
The ROIC has grown by 13% YoY but it has contracted by 4.7% from the previous quarter
Encompass Health's ROE has decreased by 8% from the previous quarter but it has increased by 4.8% YoY
Encompass Health's ROS has decreased by 5% from the previous quarter but it has increased by 3.4% YoY

Dividends

What is EHC's dividend history
DPS
$1.12
Dividend yield
2.32%
Payout ratio
28.3%
Recent dividends

Financial health

How did Encompass Health financials performed over time
The total assets is 54% greater than the total liabilities
The total assets is up by 6% year-on-year
Encompass Health's quick ratio has increased by 3.7% QoQ
The debt is 78% more than the equity
The company's equity rose by 19% YoY and by 3.3% QoQ
Encompass Health's debt to equity has decreased by 17% YoY and by 3.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.